首页> 外文期刊>Hawaii medical journal >Intranasal Corticosteroids and Central Serous Chorioretinopathy: A Report and Review of the Literature
【24h】

Intranasal Corticosteroids and Central Serous Chorioretinopathy: A Report and Review of the Literature

机译:鼻内皮质类固醇和中央性浆液性脉络膜视网膜病变:文献报道和综述。

获取原文
           

摘要

A 43-year-old male with a history of allergic rhinitis on chronic intranasal corticosteroids presented with complaints of a “black band” in his right eye visual field. On examination, he had subretinal fluid and lab tests and imaging studies including optical coherence tomography (OCT) and fluorescein angiography (FA) did not show any evidence of inflammatory, degenerative, or malignant process. He was diagnosed with central serous chorioretinopathy (CSCR). Symptoms improved and the subretinal fluid resolved after the discontinuation of intranasal corticosteroid medication. Intranasal corticosteroids are rarely associated with CSCR. Patients and providers should be aware of the potential risk of vision loss caused by intranasal corticosteroids.
机译:一名43岁的男性,患有慢性鼻内皮质类固醇过敏性鼻炎,在右眼视野中出现“黑带”的症状。接受检查时,他接受了视网膜下液和实验室检查,以及包括光学相干断层扫描(OCT)和荧光素血管造影(FA)在内的影像学研究均未显示任何炎症,退行性或恶性过程的证据。他被诊断出患有中央性浆液性脉络膜视网膜病变(CSCR)。鼻内注射皮质类固醇药物后症状改善,视网膜下液消退。鼻内皮质类固醇很少与CSCR相关。患者和提供者应注意鼻内使用糖皮质激素引起的视力丧失的潜在风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号